Sodium bicarbonate in plastic container and Agranulocytosis - a phase IV clinical study of FDA data

Summary:

Agranulocytosis is reported as a side effect among people who take Sodium bicarbonate in plastic container (sodium bicarbonate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Leucovorin Calcium, and have Ovarian cancer recurrent.

The phase IV clinical study analyzes which people have Agranulocytosis when taking Sodium bicarbonate in plastic container. It is created by eHealthMe based on reports of 1,119 people who have side effects when taking Sodium bicarbonate in plastic container from the FDA, and is updated regularly.

What is Sodium bicarbonate in plastic container?

Sodium bicarbonate in plastic container has active ingredients of sodium bicarbonate. eHealthMe is studying from 1,129 Sodium bicarbonate in plastic container users. Check the latest studies of Sodium bicarbonate in plastic container.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,327 drugs and 3,591 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

On Jul, 09, 2026

1,119 people reported to have side effects when taking Sodium bicarbonate in plastic container.
Among them, 36 people (3.22%) have Agranulocytosis.

Could Sodium bicarbonate in plastic container cause Agranulocytosis?

Among these 36 people:

How long have people been on Sodium bicarbonate in plastic container when they have Agranulocytosis? *

What is the gender of people who have Agranulocytosis when taking Sodium bicarbonate in plastic container? *

female: 50 %
male: 50 %

What is the age of people who have Agranulocytosis when taking Sodium bicarbonate in plastic container? *

What are other drugs people take besides Sodium bicarbonate in plastic container? *

What are other side effects people have besides Agranulocytosis? *

Fever: 9 people, 25.00%
Thrombocytopenia (decrease of platelets in blood): 8 people, 22.22%
Acute Kidney Failure: 6 people, 16.67%
Haemoglobin Decreased: 5 people, 13.89%
Hyperkalemia (damage to or disease of the kidney): 4 people, 11.11%
Gastrointestinal Perforation (hole in the digestive tract): 3 people, 8.33%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 8.33%
Cough: 3 people, 8.33%
Nausea (feeling of having an urge to vomit): 3 people, 8.33%
Dehydration (dryness resulting from the removal of water): 3 people, 8.33%

What are the existing conditions these people have? *

Ovarian Cancer Recurrent (reoccurrence of ovary cancer): 3 people, 8.33%
Multiple Myeloma (cancer of the plasma cells): 2 people, 5.56%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 2.78%
Gastroesophageal Cancer: 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Sodium bicarbonate in plastic container and have Agranulocytosis?

- Check whether Agranulocytosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sodium bicarbonate in plastic container:

Sodium bicarbonate in plastic container (1,129 reports)

Agranulocytosis treatments and more:

Agranulocytosis (213,267 reports)

Browse all side effects of Sodium bicarbonate in plastic container:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Agranulocytosis:

Agranulocytosis (2,327 drugs)

Browse all the conditions that are associated with Agranulocytosis:

Agranulocytosis (3,591 conditions)

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sodium bicarbonate (the active ingredients of Sodium bicarbonate in plastic container) and Sodium bicarbonate in plastic container (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.